LifeNome - Precision Health AI Platform Powered Genomics AI

LifeNome leverages biological, physiological, behavioral, environmental data to power hyper-personalized health and well-being using its enterprise platform.

  • Stage $3M in TTM Revenue
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded April 2016
  • Employees 30
  • Incorporation Type C-corp
  • Website lifenome.com

Company Summary

LifeNome is a B2B Precision Health and Wellness AI Platform. LifeNome's Genomics AI leverages biological, physiological, and behavioral data to perform one of the most comprehensive health and wellness needs assessment currently on the market, and provides program and product personalization for leading global nutrition, fitness, insurance and beauty brands (with cumulative annual revenue of $100B+) as well as health care systems.

Team

  • Ali Mostashari, Ph.D
    Co-Founder and Chief Executive Officer

    MIT PhD, Top 25 Cited Scholar in Complexity Science in the World.
    Past: Vizp, Stevens, UNDP, and MIT

  • Raya Khanin
    Co-Founder and Chief Science Officer

    Weizmann PhD, Top 25 Cited Scholar in Computational Genomics in the World. Past: the Royal Society Dorothy Hodgkin Fellow, University of Cambridge

  • Mario Storga
    Co-Founder and VP of Data Science

    UNIZG PhD, Full Professor at the University of Zagreb. Top 20 Cited Scholar in Semantic Networks in the World. Past: Vizp, Stevens, Royal Academy of Eng. UK Distinguish Research Fellow, Lulea TU

  • Teymour Farman-Farmaian
    Business Development Associate

  • Raphael Potter
    Business Development Associate

Previous Investors

  • Alex Farman-Farmaeian
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free